Search - tctmd.com

Displaying 701 - 720 of 851

Sort: Relevancy | Date

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All!

Presenter: C. Michael Gibson, Marco Valgimigli, Guido Parodi

October 11, 2015

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Presenter: C. Michael Gibson, Marco Valgimigli, Harvey D. White

October 11, 2015

Presentation TCT 2015

Case Resolution: How Did We Treat Our STEMI Patient With Multivessel Disease (and What Were the Long-term Outcomes)?

Presenter: Thomas Engstroem, Barry D. Rutherford, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Case Introduction: A STEMI Patient With Multivessel Disease

Presenter: Thomas Engstroem, Barry D. Rutherford, Henning Kelbæk

October 11, 2015

Presentation TCT 2015

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Antoniucci

October 11, 2015

Presentation TCT 2015

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Presenter: Thomas Engstroem, Barry D. Rutherford, David Erlinge

October 11, 2015

Presentation TCT 2015

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Presenter: Thomas Engstroem, Barry D. Rutherford, Colin Berry

October 11, 2015

Presentation TCT 2015

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Presenter: Thomas Engstroem, Barry D. Rutherford, Anthony H. Gershlick

October 11, 2015

Presentation TCT 2015

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Presenter: Thomas Engstroem, Barry D. Rutherford, Shamir R. Mehta

October 11, 2015

News Daily News

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

September 24, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Industry News

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

August 31, 2015

News Conference News ESC 2015

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Caitlin E. Cox

August 30, 2015

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Daily News

在STEMI中心接受治疗可改善心脏骤停结果

Yael L. Maxwell

June 19, 2015

News Daily News

Treatment at a STEMI Center Boosts Cardiac Arrest Outcomes

Yael L. Maxwell

June 19, 2015

News Daily News

El Tratamiento en un Centro STEMI Potencia los Resultados de las Paradas Cardíacas

Yael L. Maxwell

June 19, 2015

Presentation

Association Between Treatment at a STEMI Center and Neurologic Recovery Following Out-of-Hospital Cardiac Arrest

Presenter: Bryn E. Mumma

June 18, 2015

Advertisement

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? Oral or Crushed Ticagrelor for All!

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Case Resolution: How Did We Treat Our STEMI Patient With Multivessel Disease (and What Were the Long-term Outcomes)?

Case Introduction: A STEMI Patient With Multivessel Disease

Impact of CTO Revascularization After Primary PCI for AMI: Is This Where the Benefit Lies?

Nonculprit Lesions in STEMI Patients With Multivessel Disease: Is the Issue Ischemia or Vulnerable Plaque?

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Updated Meta-analysis of Culprit Only vs Complete Revascularization in STEMI: Are We Impacting Death and Reinfarction or Repeat Revascularization Only?

Introduction: A Critical Appraisal of Culprit Only vs Multivessel Intervention in STEMI Targets, Guidance, Data Review, and Future Directions

Public Reporting of PCI Mortality Tied to Fewer High-Risk Cases But Better Outcomes

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

Registry Charts Trends in Mechanical Circulatory Support During PCI

Medtronic Study Detects Gene Associated with Sudden Cardiac Death

ALBATROSS: Aldersterone Blockade Fails to Improve Outcomes in Acute MI

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

在STEMI中心接受治疗可改善心脏骤停结果

Treatment at a STEMI Center Boosts Cardiac Arrest Outcomes

El Tratamiento en un Centro STEMI Potencia los Resultados de las Paradas Cardíacas

Association Between Treatment at a STEMI Center and Neurologic Recovery Following Out-of-Hospital Cardiac Arrest

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content